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Abstract
During the inflammatory response that drives atherogenesis, macrophages accumulate
progressively in the expanding arterial wall1,2. The observation that circulating monocytes give
rise to lesional macrophages3–9 has reinforced the concept that monocyte infiltration dictates
macrophage build-up. Recent work indicates, however, that macrophages do not depend on
monocytes in some inflammatory contexts10. We therefore revisited the mechanism of
macrophage accumulation in atherosclerosis. We show that murine atherosclerotic lesions
experience a surprisingly rapid, 4-week, cell turnover. Replenishment of macrophages in these
experimental atheromata depends predominantly on local macrophage proliferation rather than
monocyte influx. The microenvironment orchestrates macrophage proliferation via the
involvement of scavenger receptor (SR)-A. Our study reveals macrophage proliferation as a key
Correspondence: F.K.S. (fswirski@mgh.harvard.edu), Center for Systems Biology, Massachusetts General Hospital, Harvard Medical
School, Simches Research Building, 185 Cambridge St., Boston, MA 02114; phone, 617-724-6242, fax, 617-726-5708. C.S.R.
(clint.robbins@utoronto.ca), Division of Advanced Diagnostics, Toronto General Research Institute, University Health Network,
Toronto Medical Discovery Tower, 101 College St., Toronto, ON M5G1L7; phone, 416-581-7510.
*authors contributed equally
Authors contributions
C.S.R. and I.H. conceived the project, designed and performed experiments, analyzed and interpreted data. G.F.W., I.T., L.M.S.G,
D.S., C.J.Z., E.A.S performed experiments and helped to interpret the data; J.L.F., R.G., I.H. performed animal surgeries; Y.I.
performed the immunofluorescence histology and immunohistochemistry; M.P. performed ImageStreamX™ Mark II studies; G.K.S.,
P.L., M.N., M.H. and R.W. provided materials, intellectual input, and edited the manuscript; N.v.R. provided clodronate liposomes;
H.Y.L. edited the manuscript. F.K.S. conceived the project, designed experiments, and supervised the study. C.S.R. and F.K.S. wrote
the manuscript.
Author information
The authors declare no competing financial interests. Correspondence and requests for materials should be addressed to F.K.S.
(fswirski@mgh.harvard.edu), Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Simches
Research Building, 185 Cambridge St., Boston, MA 02114; phone, 617-724-6242, fax, 617-643-6133 or C.S.R.
(clint.robbins@utoronto.ca), Division of Advanced Diagnostics, Toronto General Research Institute, University Health Network,
Toronto Medical Discovery Tower, 101 College St., Toronto, ON M5G1L7; phone, 416-581-7510.
NIH Public Access
Author Manuscript
Nat Med. Author manuscript; available in PMC 2014 March 01.
Published in final edited form as:
Nat Med. 2013 September ; 19(9): 1166–1172. doi:10.1038/nm.3258.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
event in atherosclerosis and identifies macrophage self-renewal as a therapeutic target for
cardiovascular disease.
Over the last 30 years macrophages have emerged as protagonists of atherosclerosis and its
complications. Macrophages amass in lesions, ingest lipids, and produce a diverse repertoire
of inflammatory mediators that exacerbate disease1,2. In the mouse, lesional macrophages
arise predominantly from circulating Ly-6Chigh monocytes5–7,11–13. These insights have
contributed to the perception that macrophages gradually accrue in atherosclerotic lesions
whereby a single infiltrating monocyte yields one terminally-differentiated macrophage.
Recent observations that monocyte kinetics in acute injury are rapid14, that tissue
macrophages may not depend on monocytes10,15, and that the adventitia harbors
hematopoietic progenitors16 reveal potential alternative explanations for how atherosclerosis
evolves. The prevailing models, therefore, require reevaluation.
Do lesional macrophages in atherosclerosis accumulate gradually or turn over rapidly? To
answer, we subcutaneously implanted osmotic pumps containing the thymidine analogue 5-
bromo-2′-deoxyuridine (BrdU) in 4-month old apolipoprotein E-deficient (Apoe−/−) mice
consuming a high cholesterol diet (HCD) for 8 weeks. BrdU incorporates into newly
synthesized DNA and thus reports on a cell’s, or its progenitor’s, proliferative history.
Nearly all (92±1%) aortic macrophages, identified as Lin− CD11b+CD11clow-negF480high
cells by flow cytometry (Fig. 1a), stained for BrdU after 4 weeks (when mice were 5 months
old) (Fig. 1b and c). Immunofluorescence experiments identified Mac3+BrdU+ macrophages
within the plaque intima and adventitia (Fig. 1d–f). This low-level BrdU administration had
no intrinsic effect on macrophage turnover kinetics because the rate of BrdU signal decay
following pump removal closely approximated its rate of incorporation (Fig. 1c). Despite
observed increases in lesion size (Fig. 1g), aortic root macrophage burden did not change
significantly during BrdU labeling (Fig. 1h), suggesting that, at this stage of atherosclerosis,
cell loss processes counterbalance macrophage renewal. These data identify a previously
unrecognized dynamic in the mononuclear phagocytic response during atherosclerosis and
reveal remarkably rapid macrophage turnover in lesions.
Lesional macrophages could replenish either through the continuous recruitment of
circulating monocytes or through some other processes. We assessed lesional macrophage
accumulation in Apoe−/− HCD mice depleted of circulating monocytes for 5 d (Fig. 2a) and
found, unexpectedly, that monocyte depletion had no effect, not only on incorporation of
BrdU by lesional macrophages (Fig. 2b and c) but also on the number of total macrophages
(Fig. 2d) and total lesion area (Supplementary Fig. 1a). To examine the relationship between
blood monocytes and tissue macrophages in more detail, 4-month old CD45.1+ Apoe−/−
HCD and CD45.2+ Apoe−/−HCD mice (8 weeks of Western diet) were joined for 5 weeks by
parabiosis, a procedure that allows circulating cells to enter partner tissues17. The procedure
did not alter the frequency of monocytes in the blood (Supplementary Fig. 1b) and had no
effect on BrdU incorporation in lesional macrophages (Supplementary Fig. 1c). Whereas
Ly-6Chigh monocyte chimerism in the blood (30±5%), spleen (26±4%), and aorta (25±6%)
was high – and typical of monocyte chimerism at equilibrium18 – macrophage chimerism in
the aorta was low (5±2%) (Fig. 2e–g). Therefore, in established disease, the discrepancy
between monocyte and macrophage chimerism illustrates either slow macrophage
replenishment or macrophage replenishment that does not rely exclusively on monocyte
influx. Because macrophages replenish rapidly in established disease (~4 weeks, Fig. 1),
macrophage accumulation likely occurs through processes other than monocyte infiltration.
Surgical separation of parabionts provided complementary evidence in support of this
conclusion. Separation led to a decline in monocyte chimerism in blood, spleen and aorta,
but chimerism among lesional macrophages remained unchanged for at least 2 weeks (Fig.
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2h). Together, these data show that monocyte recruitment cannot fully account for lesional
macrophage accumulation in established atherosclerosis.
Macrophage turnover that is largely independent of monocytes does not preclude the initial
development of plaque macrophages from hematopoietic precursors. To determine when
monocytes and macrophages converge, relatively young (early atherosclerosis) mice were
joined in parabiosis for 1 and 4 weeks. Unlike established disease (Fig. 2e–g), monocyte and
macrophage chimerism in these mice was similar (Supplementary Figure 2a), which is
aligned with previous observations that early development of atherosclerotic lesions depends
on monocyte recruitment19. To determine if monocytes and macrophages converge in
established disease, we lethally irradiated and reconstituted 4-month old CD45.2+Apoe−/−
HCD mice with bone marrow from CD45.1+Apoe−/− mice. Over 5 months, lesional
macrophages in these animals with established plaques were eventually replenished by
donor-derived CD45.1+ cells (Supplementary Fig. 2b). These data suggest that, even though
rapid lesional macrophage turnover does not require constant monocyte influx, aortic
macrophages ultimately derive from a circulating precursor.
The recent identification of hematopoietic progenitors in the aortic adventitia16 raised the
possibility that lesional macrophages arise from circulating intima-seeded multipotent
hematopoietic stem and progenitor cells (HSPC). To address this, we performed
granulocyte-macrophage colony forming experiments on aortic tissue. As shown
previously11, HSPC were highly active in the bone marrow and spleen of Apoe−/− HCD
mice (Fig. 3a). The entire aorta, on the other hand, yielded no more than 2 macrophage
colonies per animal. These data accord with the recent study on HSPC activity in the
vascular wall16, and indicate that local hematopoiesis of a multiproliferative progenitor
contributes minimally to lesional macrophage accumulation in atherosclerosis.
Macrophage proliferation in atherosclerotic lesions has been identified in humans, rabbits
and mice20–26 but its importance relative to monocyte recruitment has not been evaluated.
We addressed this by several independent and complementary approaches. First, we
adoptively transferred Ly-6Chigh monocytes from GFP+ mice to Apoe−/− mice consuming
HCD. 24 h following transfer, we also injected BrdU to track proliferation. 2 d after BrdU
pulse, non-proliferating BrdU−GFP+ monocytes were detected in the recipient blood (Fig.
3b). In the aorta, GFP+ cells grouped into F480low BrdU− cells, representing a few
monocytes that had accumulated but neither differentiated nor proliferated, and F480high
cells, representing monocyte-derived macrophages, some of which had proliferated locally
(BrdU+) (Fig. 3b). The data indicate that proliferating lesional macrophages derive from
non-proliferating circulating monocytes. Future studies will need to determine whether
lesion-infiltrating monocytes, in addition to differentiation, die locally or exit. Second, we
performed a 2 h in vivo BrdU-pulse labeling experiment, used previously to detect
neointimal dendritic cell proliferation19. At a time when circulating monocytes had not yet
incorporated BrdU (Supplementary Fig. 3a), macrophages in both Apoe−/− (Fig. 3c) and
Low Density Lipoprotein Receptor-deficient (Ldlr−/−) (Supplementary Fig. 3b) mice were
already BrdU+, indicating local proliferation. Third, analysis of the S and G2/M phases of
the cell cycle using the intercalating dye 4′,6-diamidino-2-phenylindole (DAPI) revealed a
high percentage of proliferating aortic macrophages in Apoe−/−mice consuming a high
cholesterol diet (Fig. 3d). This finding contrasted with macrophages from wild type (WT)
and young (2 month old) chow-fed Apoe−/− mice, which proliferated less, and monocytes,
which did not proliferate under any circumstances (Fig. 3b, d, e). Fourth, positive staining of
gated G2/M-phase lesional macrophages for phospho-histone H3 confirmed mitosis (Fig.
3f). Fifth, to directly visualize cell division, we utilized the ImageStreamX™ Mark II
platform, an approach that links multi-parameter flow cytometry with single cell immuno-
fluorescence imaging. Analysis of Apoe−/− HCD mice showed G2/M-phase aortic
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macrophages in various phases of mitosis (Fig. 3g). Sixth, immunofluorescence of aortic
root sections showed numerous intimal Mac3+ macrophages staining positive for the nuclear
proliferation antigen Ki67 (Fig. 3h). The key to interpreting these last four experiments is
the ability of DAPI, phospho-histone H3, and Ki67 to identify currently – rather than
formerly – proliferating cells. The colocalization of markers of cell division with mature
macrophage markers (F480 by flow cytometry and Mac3 by immunofluorescence) indicates
that lesional macrophages proliferate. Finally, immunohistochemistry of atherosclerotic
plaques from human carotid arteries revealed Ki67-expressing oil red O+ and CD68+
lesional macrophages (Supplementary Fig. 3c), indicating that in situ proliferation of mature
intimal macrophages occurs in experimental and human atherosclerosis. While classic
studies have shown that the dominant proliferative cell type in the human intima is the
monocyte/macrophage in both early23 and advanced atherosclerosis21,22, it remains to be
determined whether local macrophage proliferation contributes substantially to human lesion
growth, turnover, and rupture.
To quantify the contribution of local proliferation to macrophage accumulation in
established atherosclerotic lesions, 4 month-old CD45.1+ Apoe−/− HCD and CD45.2+
Apoe−/− HCD (8 weeks on diet) mice were joined by parabiosis and implanted with BrdU-
containing osmotic pumps for 4 weeks (Fig. 3i). This experiment allowed assessment of
macrophage chimerism exclusively in newly accumulating BrdU+ macrophages. Among
newly accumulating macrophages in CD45.1+ aortas, only 4% were CD45.2+ (Fig. 3i),
which agrees with our previous observations and further argues against macrophage
residential longevity as the determining factor for low chimerism (Fig. 2e and f). Aortic
chimerism alone underestimates the overall contribution of circulating monocytes because
monocyte chimerism in the blood, even at equilibrium, is only ~30% (Fig. 3i). Therefore,
assuming that individual CD45.1+ and CD45.2+ cells can infiltrate lesions equally, for every
partner-derived (i.e., CD45.2+) monocyte that entered the CD45.1+ aorta, ~2 endogenous
(i.e., CD45.1+) monocytes also entered. Hence, the total contribution of the circulation
(CD45.1+ and CD45.2+) to macrophage accumulation in a 4-week period in established
disease can be, at most, ~13% (Fig. 3j). Local proliferation, which accounts for the
remaining ~87% of newly-labeled BrdU+ macrophages, dominates macrophage
accumulation in established atherosclerosis (Fig. 3j). Similar studies conducted during early
atherosclerosis, when lesional macrophage burden was still minimal (Supplementary Fig.
2a), demonstrated a larger contribution of recruited monocytes to macrophage accumulation
(Fig. 3j). Collectively, these data show that, as atherosclerosis progresses, macrophage
turnover becomes increasingly dependent on local proliferation of lesional macrophages.
Since lesional macrophages reside in a tissue context, macrophage proliferation might
depend on the local microenvironment. We addressed this possibility with several
approaches. First, we joined 4 month-old WT (C57BL6/J, CD45.1+) and Apoe−/−(CD45.2+)
HCD mice by parabiosis. The joined heterogenic partners consumed a high cholesterol diet
for 5 weeks. During this period, atherosclerotic lesions persisted in Apoe−/− partners but did
not develop in WT partners. Among the cells accumulating in aortas, lesional macrophage
chimerism remained low (Fig. 4a), although the WT aorta contained fewer total cells.
Whatever the cell’s origin (host or partner, Apoe−/− or WT) macrophages accumulating in
Apoe−/− mice were more likely to proliferate compared to macrophages accumulating in WT
mice (Fig. 4a and b). We also assessed macrophage proliferation in Apoe−/− HCD mice in
different aortic segments of the same animal. Proliferation was highest among macrophages
located in the aortic root and arch (where lesions are most abundant), intermediate among
macrophages located in the thoracic aorta (intermediate abundance), and lowest in the
abdominal aorta (least abundance) (Supplementary Fig. 4). To discriminate between lesional
and adventitial macrophage proliferation, the intima was separated from the vessel wall, as
previously described27. Whereas adventitial macrophages proliferated at a rate similar to
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that observed in young non-atherosclerotic mice, lesional macrophages proliferated at a high
rate (Fig. 4c). Thus, the microenvironment influences macrophage proliferation.
By what mechanism are lesional macrophages proliferating? Neither neutralizing antibody
nor genetic studies targeting GM-CSF affected macrophage proliferation (Supplementary
Fig. 5a and b), which was somewhat surprising given the growth factor’s known role in
macrophage differentiation and neointimal DC proliferation19. We turned our attention to
the type 1 scavenger receptor class A (SR-A, also known as Msr1), which is expressed on
lesional macrophages28,29, recognizes modified low-density lipoproteins30, and correlates
with macrophage proliferation31. We generated mixed chimeric mice by irradiating and
reconstituting Ldlr−/− mice with a mixture of WT CD45.1+ and Msr1−/− CD45.2+ bone
marrow cells (Fig. 4d). This approach allowed us to compare proliferation of Msr1-
competent and deficient macrophages in the same lesional microenvironment. After 16 wk
of HCD, bone marrow transplantation was associated with engraftment and circulation of
moderately fewer Msr1−/−CD45.2+ monocytes compared to WT CD45.1+ monocytes
(Supplementary Fig. 5c). In the aorta, we observed ~60% fewer Msr1−/−CD45.2+
macrophages compared to WT CD45.1+ cells (Supplementary Fig. 5d) When animals were
pulsed with BrdU for 2h, circulating monocytes were almost entirely BrdU− regardless of
genotype (Fig. 4e). Compared to WT cells, Msr1−/− macrophages proliferated less (Fig. 4f)
and BrdU+ Msr1−/− macrophages were far less abundant in lesions (Fig. 4g). These data
indicate that Msr1 contributes to the life cycle of proliferating macrophages in established
atherosclerosis. Future work will need to elucidate whether the effect is direct or indirect,
and investigate the mechanistic links between Msr1-mediated apoptosis, ER stress, and
proliferation31,32.
The finding that local macrophage proliferation contributes substantially to lesional
macrophage accumulation prompted us to test whether interference with proliferation can
reduce established atherosclerosis. Apoe−/− HCD mice received the cell cycle inhibitor
fluorouracil (5-FU). It is known that 5-FU decreases the production of monocytes33.
However, the drug was delivered for only 4 weeks, a period of time in which monocytes
contribute little to macrophage accumulation in established atherosclerosis. 5-FU
significantly decreased the rate (Supplementary Fig. 6a) and number (Supplementary Fig.
6b) of proliferating aortic macrophages. The overall effect of 5-FU resulted in fewer Mac3+
macrophages and smaller lesions (Supplementary Fig. 6 c–e). These data are consistent with
studies in which genetic disruption of tumor suppressor genes and cell cycle regulators
promoted macrophage proliferation and increased atherosclerosis34,35. These findings
demonstrate that cellular proliferation is a dominant feature of atherosclerotic development
and a potent therapeutic target.
Atherosclerosis is a lipid-driven inflammatory disease characterized by monocyte
recruitment and differentiation1. When lesions regress, monocyte recruitment is
suppressed13. Our study builds on this paradigm by providing evidence that, in addition to
monocyte recruitment and differentiation, monocyte-derived lesional macrophages
proliferate. Atherosclerosis develops, our data indicate, via a multiphasic numerical
escalation of the monocyte-macrophage lineage. Its sequence can be summarized as follows:
(1) hematopoietic stem cells proliferate in the bone marrow and spleen and give rise to
monocytes11,36,37; (2) Monocytes circulate, infiltrate, and differentiate to
macrophages5–7,13; (3) Lesional macrophages proliferate and locally augment their numbers
in plaques (Fig. 4h). The evidence for substantial local expansion of mononuclear
phagocytes resulting from proliferation within the intimal lesion adds a new dimension to
our understanding of lesional leukokinetics. Moving forward, it will be important to evaluate
the importance of local macrophage proliferation in human atherosclerosis, and to determine
Robbins et al. Page 5
Nat Med. Author manuscript; available in PMC 2014 March 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
how interfering with monocyte recruitment and macrophage proliferation at various stages
of atherosclerosis affects plaque progression.
Online Methods
Animals
C57BL/6J (wild-type, WT), B6.SJL-PtprcaPep3b/BoyJ (CD45.1+), apolipoprotein E–
deficient (Apoe−/−; B6.129P2-Apoetm1Unc), low density lipoprotein-deficient (Ldlr−/−;
B6.129S7-Ldlrtm1Her/J) and macrophage scavenger receptor 1-deficient (Msr1−/−; B6.Cg-
Msr1tm1Csk/J) mice were purchased from The Jackson Laboratories. Mice deficient in the β-
subunit of the granulocyte-macrophage colony stimulating factor receptor (Csf2rb−/−) were
kindly provided by Dr. Jeffrey Whitsett at Cincinnati Children’s Hospital Medical Center.
Apoe−/−CD45.1+ were generated after backcrossing Apoe−/− mice to C57BL/6 CD45.1+. At
6–8 wk of age, Apoe−/− mice were placed on a “Western” diet (high cholesterol diet, HCD)
(21.2% fat weight−1; 0.2% cholesterol) (Harlan Teklad, Madison, WI) or remained on a
chow diet for durations listed in the manuscript. Ldlr−/− mice were fed a high fat/cholesterol
diet (D12108C: 20% fat/weight; 1.25% cholesterol) (Research Diets Inc., New Brunswick,
NJ). All mice were female except Ldlr−/−, which were male. All protocols were approved by
the Institutional Animal Care and Use Committee (IACUC), Subcommittee on Research
Animal Care (SRAC), Massachusetts General Hospital, Charlestown, MA.
Animal models and in vivo interventions
BrdU incorporation studies: BrdU was administered using osmotic mini-pumps implanted
subcutaneously (Alzet model 1002) at a dose of 50 μg day−1 or injected i.v. at 1mg mouse−1.
Monocyte depletion: Mice were i.v. injected daily with 200 μl clodronate loaded liposomes.
Clodronate was a gift from Roche and was incorporated into liposomes are described
previously38. Parabiosis: The procedure, adapted from17 was conducted as previously
described39. Briefly, after shaving the corresponding lateral aspects of each mouse,
matching skin incisions were made from behind the ear to the tail of each mouse, and the
subcutaneous fascia was bluntly dissected to create about 0.5 cm of free skin. The scapulas
were sutured using a mono-nylon 5.0 (Ethicon, Albuquerque, NM), and the dorsal and
ventral skins were approximated by continuous suture. Mice were joined for intervals of 4 to
5 weeks. In one set of experiments, after an interval of 5 weeks joined, parabiosed mice
were surgically separated by a reversal of the procedure. Percent chimerism in the blood and
aortic tissue was defined for either gated monocytes or macrophages as %CD45.1+
(%CD45.1+ & %CD45.2+)−1 in CD45.2+ mice, and as %CD45.2+ (%CD45.2+ &
%CD45.1+)−1 in CD45.1+ mice. Bone marrow chimeras: Ldlr−/− HCD mice with established
atherosclerosis were lethally irradiated (950cGy) and reconstituted with CD45.1+ wild type
(WT) bone marrow. For generation of mixed chimeras naive Ldlr−/− mice were lethally
irradiated and reconstituted with a 50:50 mix of bone marrow cells from CD45.1+ wild type
mice and CD45.2+ knockouts for SR-A I/II (Msr1−/−) and the GM-CSF receptor β-chain
(Csf2rb−/−) respectively. Adoptive transfer: Ly-6Chigh CD115+ monocytes were sorted from
GFP+ mice. 3 × 106 cells were injected i.v. into Apoe−/− mice consuming HCD for 12
weeks. Treatment: Fluorouracil (5-FU) (APP Pharmaceuticals, LLC, USA) was
administered via osmotic mini-pumps at a dose of 15 mg kg−1 per day for 4 weeks with two
intermittent boluses of 100 mg kg−1 iv. Anti-GM-CSF antibody (functional grade
MP1-22E9, eBioscience) was delivered i.v. at a dose of 100 μg (mouse day)−1.
Cells
Peripheral blood for flow cytometric analysis was collected by cardiac puncture, using a 50
mM EDTA solution as anticoagulant. Erythrocytes were lysed using BD FACS Lysing
Solution (BD Biosciences). Total white blood cell count was determined by preparing a 1:10
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dilution of (undiluted) peripheral blood obtained from the orbital sinus using heparin-coated
capillary tubes in RBC Lysis Buffer (BioLegend). After organ harvest, single cell
suspensions were obtained as follows: for bone marrow, femur and tibia of one leg were
flushed with PBS. Spleens were homogenized through a 40 μm-nylon mesh, after which
erythrocyte lysis was performed on the spleens using RBC Lysis Buffer (BioLegend). For
aortic tissue, the entire aorta was digested (from the root to the iliac bifurcation) according
to a method previously published40. The procedure involves perfusion of the aorta (20 ml
PBS) prior to digestion. Aortic tissue was cut in small pieces and subjected to enzymatic
digestion with 450 U ml−1 collagenase I, 125 U ml−1 collagenase XI, 60 U ml−1 DNase I
and 60 U ml−1 hyaluronidase (Sigma-Aldrich, St. Louis, MO) for 1 h at 37 °C while
shaking. Total viable cell numbers were obtained using Trypan Blue (Cellgro, Mediatech,
Inc, VA). To separate intimal lesions from the media and adventitia we adapted the method
previously described by Butcher et al27. In brief, aortas were cut open longitudinally and
pinned onto black wax with the intimal area facing upwards. A thin film of enzymatic
digestion mixture was applied directly onto the exposed intima. After 15 min of incubation
at room temperature lesions were scraped off the underlying media with a glass coverslip.
Lesional tissue and the remaining media and adventitia were cut into small pieces and
separately digested for 40 min at 37 °C while shaking as described above. Tissue colony
forming cell assay: To determine the number of myeloid colony-forming units, a single cell
suspension was prepared from bone marrow, spleens and aortic tissue and 1×105 cells were
plated in triplicates in complete methylcellulose medium (MethoCult GF M3434, Stemcell
Technologies). Counts were performed after 8 d of culture. At least three independent
samples per group were analyzed.
Flow Cytometry
The following antibodies were used for flow cytometric analyses: anti-CD90.2-PE, 53–2.1
(BD Biosciences); anti-B220-PE, RA3-6B2 (BD Biosciences); anti-CD49b-PE, DX5 (BD
Biosciences); anti-NK1.1-PE, PK136 (BD Biosciences); anti-Ly-6G-PE, 1A8 (BD
Biosciences); anti-TER119-PE, TER119 (BD Biosciences); anti-CD11b-APCcy7, M1/70
(BD Biosciences); anti-CD11c-Alexa Fluor 700, HL3 (BD Biosciences); anti-IAb-Percp
Cy5.5, AF6-120.1 (BD Biosciences); anti-F480-PE-Cy7, BM8 (BioLegend); anti-CD45.2-
FITC, 104 (BD Biosciences); anti-CD45.1-APC, A20 (BD Biosciences); anti-CD115-APC,
AFS98 (ebioscience). Antibody dilutions were 1:300 – 1:700. Cell cycle analysis was
carried out using FxCycle violet stain (Invitrogen). Contribution of newly-made cells to
different cell populations was determined by in vivo labeling with bromodeoxyuridine
(BrdU) (BD Biosciences). Incorporation was measured using either FITC or APC-
conjugated anti-BrdU antibodies according to the manufacturer’s instructions. Monocytes
and macrophages were identified similarly as described previously39. Specifically,
monocytes were identified as CD11bhi Lin− (Lin = CD90/B220/CD49b/NK1.1/Ly-6G/
Ter119) F480lo. Macrophages were identified as CD11bhi Linlo F480hi CD11clo-neg. Data
were acquired on an LSRII (BD Biosciences) and analyzed with FlowJo v8.8.6 (Tree Star,
Inc.). The ImageStreamX™ imaging flow cytometry platform was used to analyze the cell
cycle as per manufacturer’s instructions.
Histology
Atherosclerotic plaque specimens were obtained from patients undergoing carotid
endarterectomies. Carotid tissue was obtained from cardiac transplants by protocols
approved by the Human Investigation Review Committee at the Brigham and Women’s
Hospital. Specimens were immediately immersed in saline solution, transported to the
laboratory on ice (within 1 hr), embedded in OCT compound, and stored at −80°C freezer
until use. Serial cryostat sections (5 μm) are cut, air dried onto microscope slides (Fisher
Scientific, Pittsburgh, PA) and used for immunohistochemistry. Mouse aortae were excised,
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embedded in O.C.T. compound (Sakura Finetek), and flash-frozen in isopentane and dry ice.
Aortic roots were sectioned into 5 um slices, generating ~30–40 sections that spanned the
entirety of the aortic root. For comparison of lesion size between the groups, sections that
captured the maximum lesion area were used. Immunofluorescence double staining was
carried out using BrdU Flow Kits (BD Biosciences), Mac-3: clone M3/84 (BD Biosciences)
and FITC-Ki67: clone SP6 (Abcam). For BrdU immunofluorescence double staining, the
sections were stained with Mac-3 antibody followed by a biotinylated secondary antibody
and streptavidin-Texas Red (GE Healthcare). To denature DNA, the sections were incubated
with 2 N HCl for 10 min at room temperature and for 20 min at 37 °C. Acid neutralization
was achieved by immersing sections in 0.1M borate buffer. Cover slips were placed over
specimens using mounting medium containing DAPI (Vector Laboratories) to identify cell
nuclei. Images capture was performed using an epifluorescence microscope (Nikon Eclipse
80i, Nikon Instruments Inc.) equipped with a Cascade Model 512B camera (Roper
Scientific). For immunohistochemistry, anti-CD45.1: clone A20 (eBioscience), anti-CD45.2:
clone 104 (BioLegend), anti-Mac-3: clone M3/84 (BD Biosciences) was used for mouse
aortic root sections, and anti-Ki67 (abcam), anti-CD68: clone KP1 (Dako) were used to stain
human carotid arteries. In order to block endogenous peroxidase activity, tissue sections
were pre-treated with 0.3% hydrogen peroxide solution. Following application of the
appropriate biotinylated secondary antibodies, samples were developed using the Vectastain
ABC kit (Vector Laboratories) and either AEC (DakoCytomation) or DAB (Vector
Laboratories) substrates. Sections were counterstained with Harris Hematoxylin and
specificity of staining was confirmed using relevant isotype controls. Masson trichrome
(Sigma) and Oil Red O (Sigma) staining were performed to visualize collagen and lipid
content, respectively. Hematoxylin and eosin (H&E) staining was performed to assess
overall tissue morphology. Images were digitized using a Nanozoomer 2.0RS (Hamamatsu).
Statistics
Results were expressed as mean ± SEM. Statistical tests included unpaired Student’s t test
using Welch’s correction for unequal variances and 1-way ANOVA followed by Tukey’s or
Newman-Keuls Multiple Comparison Test. P values of 0.05 or less were considered to
denote significance.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Macrophages turn over rapidly in lesions
(a) Identification of aortic macrophages in established atherosclerosis. Contour plots
demonstrate gating scheme for aortic macrophages in Apoe−/− mice consuming HCD for 8
weeks. (b) BrdU-containing osmotic pumps were implanted in Apoe−/− mice consuming
HCD for 8 weeks. Data depict BrdU incorporation in aortic macrophages 1 and 4 weeks
following implantation of osmotic pumps. (c) Percentage of aortic macrophages that
incorporate BrdU. Shown is quantification of data in b as well as BrdU+ macrophages in
mice where pumps were removed for 4 weeks (mean ± SEM, n = 8 (week 1), n = 3 (week
4), n = 2 (week 4 removal)). (d) Immunofluorescence (IF) shows BrdU+ Mac3+
macrophages in aortic root lesions. (e) IF showing co-localization of BrdU and DAPI in
intimal and adventitial macrophages of aortic root sections following 4 weeks of BrdU
administration; 10x magnification. (f) Enumeration of BrdU+ Mac3+ macrophages by IF in
aortic root sections (mean ± SEM, n = 2–3). * P < 0.05. (g) Lesion growth during BrdU
labeling period. (h) Lesional macrophage content during BrdU labeling period. Data show
area staining for Mac-3.
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Figure 2. Lesional macrophage accumulation occurs largely independent of monocyte
recruitment
(a) Effect of repeated clodronate liposome administration on peripheral blood monocytes
(mean ± SEM, n = 4). (b) Effect of clodronate liposome treatment on BrdU incorporation by
aortic macrophages. Data show percentage of BrdU+ macrophages in aortic tissue following
5 d clodronate administration (mean ± SEM, n = 6–9). (c) Data show number of BrdU+
macrophages in aortic tissue following 5 d clodronate treatment (mean ± SEM, n = 6–9). (d)
Data show total number of macrophages in aortic tissue following 5 d clodronate treatment
(mean ± SEM, n = 6–9). (e) CD45.1+ and CD45.2+ Apoe−/− HCD mice were joined in
parabiosis for 5 weeks. Data show Ly-6Chigh monocyte chimerism in the blood, spleen, and
aorta and macrophage chimerism in the aortic tissue (mean ± SEM; n = 6–8). (f)
Representative contour plots demonstrate monocyte and macrophage chimerism in aortic
tissue. (g) Immunohistochemistry (IHC) of aortic root sections showing CD45.1 and CD45.2
staining in CD45.1+ parabionts. (h) CD45.1+ and CD45.2+ Apoe−/− HCD mice were joined
in parabiosis for 5 weeks, separated and assessed for chimerism 2 weeks later. Shown is
chimerism for monocytes in the blood, spleen, and aorta as well as macrophages in the aorta
(mean ± SEM; n = 4–8).* P < 0.05.
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Figure 3. In situ proliferation dominates macrophage accumulation in atherosclerosis
(a) Data show colony-forming units–granulocytes and macrophages (CFU-GM) in spleen,
bone marrow and aortic tissue of Apoe−/− HCD mice (mean ± SEM, n = 3). * P < 0.05. (b)
BrdU incorporation following adoptive transfer of GFP+ Ly6Chigh monocytes. One
representative experiment is shown. (c) BrdU pulse labeling of aortic macrophages (mean ±
SEM, n = 7). (d) Cell cycle analysis of aortic tissue macrophages. Histograms depict DAPI
staining (mean ± SEM, n = 7). * P < 0.05. (e) Percentage of aortic tissue macrophages in S
and G2/M phases of the cell cycle. (mean ± SEM, n = 3–7). * P < 0.05. (f) Phospho-histone
H3 staining of aortic macrophages in G2/M phases of the cell cycle. (g) Analysis of aortic
macrophages by ImageStreamX™ imaging flow cytometry platform. Data depict actively
dividing macrophages. (h) IF of aortic root sections demonstrating Ki-67 staining of Mac3+
intimal macrophages. (i) CD45.1+ and CD45.2+ Apoe−/− HCD mice were joined in
parabiosis and then implanted with BrdU containing osmotic pumps. Data show chimerism
in newly made (BrdU+) aortic tissue macrophages. One representative experiment of two is
shown. Monocyte chimerism in peripheral blood is also shown. (j) Relative contribution of
in situ proliferation and monocyte recruitment to macrophage accumulation in early (2–3
month old) and established (4–5 months old) atherosclerosis.
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Figure 4. Lesion microenvironment dictates macrophage proliferation
(a) WT (CD45.1+ C57BL6/J) and CD45.2+ Apoe−/− HCD mice were joined in parabiosis for
5 weeks. Data show DAPI staining in CD45.1+ and CD45.2+ aortic tissue macrophages in
each parabiont. One representative experiment of 3 is shown. (b) Enumeration of data in a.
(mean ± SEM, n = 8–9). * P < 0.05. (c) Cell cycle analysis of intimal versus adventitial
aortic macrophages. (d) WT/Msr1−/−mixed chimeras were generated by reconstituting
lethally irradiated Ldlr−/− mice with CD45.1+ wild type (Msr1+/+) and CD45.2+ Msr1–
deficient (Msr1−/−) bone marrow cells. (e) Data show number of BrdU+ Msr1+/+ (WT) and
BrdU+ Msr1−/−Ly6Chigh monocytes in blood 2 h following BrdU pulse labeling. (mean ±
SEM, n = 5). (f) Percentage of WT and Msr1−/− aortic macrophages that are BrdU+. (mean ±
SEM, n = 5).* P < 0.05. (g) Number of BrdU+ Msr1+/+and BrdU+ Msr1−/− macrophages in
aortic tissue of WT/Msr1−/− mixed chimeras. (mean ± SEM, n = 5).* P < 0.05. (h) Cartoon
depicting macrophage expansion in established atherosclerosis.
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